The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs
Rodbard HW
Diabetes Technology & Therapeutics. Pub. online 5 June 2018.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Rodbard HW
Diabetes Technology & Therapeutics. Pub. online 5 June 2018.
Leggi
Garg SK, Rewers AH, Akturk HK
Diabetes Technology & Therapeutics. Pub. online 6 June 2018.
Leggi
Katerina S, Miroslav V, Martina T, et al.
Diabetes Technology & Therapeutics. Pub. online 8 June 2018.
Leggi
Clemente G, Gallo M, Giorgini M; AMD – “Diabetes and Cancer” working group
Diabetes Res Clin Pract. 2018;S0168-8227(18)30519-9.
Leggi
Thorsen SU
American Journal of Epidemiology. 2018:187(6):1174-81
Leggi
Gray S, Cheetham T, McConachie H, et al.
Diabetic Medicine. Pub. online 26 May 2018
Leggi
Picard S, Hanaire H, Reznik Y, et al.
Diabetes Technology & Therapeutics. Pub. online 30 May 2018
Leggi
Shin WY, Kim HC, Lee T, et al.
Diabetic Medicine. Pub. online 26 May 2018
Leggi
Yang LJ and Lee Shaun Wen Huey
Diabetes Technology & Therapeutics. Pub. online 29 May 2018.
Leggi
Gafoor R, Booth HP, Gulliford MC
BMJ 2018;361:k1951
Leggi